Universities and colleges
Gene Expression Profiling Holds Promise for Stage II Colon Cancer Risk Stratification
Researchers at the University of California have discovered that conventional clinical and pathologic risk factors in stage II colon cancer provide limited prognostic information and fail to predict response to adjuvant 5-fluorouracil-based chemotherapy. This gap in knowledge has led to the need for new prognostic and predictive biomarkers to identify